XML 92 R82.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidating Financial Statements (Cash Flow) (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net cash provided by (used in) operating activities $ 471,812 $ 273,573
Cash flows from investing activities:    
Capital expenditures (60,774) (61,794)
Return of capital from investees 523 0
Investment in and loans to investees (90,080) (43,000)
Payments for acquisition of a business, net of cash acquired (35,554) 0
Increase (decrease) to investment in affiliates 0 0
Net cash (used in) provided by investing activities (185,885) (104,794)
Cash flows from financing activities:    
Deemed repurchases of restricted stock units (15,734) (13,373)
Purchase of treasury stock (267,400) (347,334)
Proceeds from stock option exercises 4,317 0
Principal payments on capital lease obligations (3,878) (3,428)
Distributions to noncontrolling interests (9,333) (16,110)
Proceeds from the issuance of long-term debt 0 1,536,000
Principal payments on long-term debt 0 (1,257,965)
Payments for financing costs 0 (10,405)
Net Cash Provided by (Used in) Financing Activities, Continuing Operations (292,028) (112,615)
Net Cash Provided by (Used in) Continuing Operations (6,101) 56,164
Effect of exchange rate changes on cash and cash equivalents 12,035 14,736
Cash and cash equivalents at end of period 564,717 552,289
Consolidation, Eliminations [Member]    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities (658,401) (611,888)
Cash flows from investing activities:    
Capital expenditures 0 0
Return of capital from investees 0  
Investment in and loans to investees 0 0
Payments for acquisition of a business, net of cash acquired 0  
Increase (decrease) to investment in affiliates 888,084 429,994
Net cash (used in) provided by investing activities 888,084 429,994
Cash flows from financing activities:    
Deemed repurchases of restricted stock units 0 0
Purchase of treasury stock 0 0
Proceeds from stock option exercises 0  
Principal payments on capital lease obligations 0 0
Distributions to noncontrolling interests 0 0
Proceeds from the issuance of long-term debt   0
Principal payments on long-term debt   0
Payments for financing costs   0
Net Cash Provided by (Used in) Financing Activities, Continuing Operations 0 0
Net Cash Provided by (Used in) Continuing Operations 229,683 (181,894)
Effect of exchange rate changes on cash and cash equivalents (229,683) 181,894
Cash and cash equivalents at end of period 0 0
Parent Company [Member]    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities 426,876 374,873
Cash flows from investing activities:    
Capital expenditures 0 0
Return of capital from investees 0  
Investment in and loans to investees 0 0
Payments for acquisition of a business, net of cash acquired 0  
Increase (decrease) to investment in affiliates (129,968) (289,891)
Net cash (used in) provided by investing activities (129,968) (289,891)
Cash flows from financing activities:    
Deemed repurchases of restricted stock units (15,734) (13,373)
Purchase of treasury stock (267,400) (347,334)
Proceeds from stock option exercises 4,317  
Principal payments on capital lease obligations 0 0
Distributions to noncontrolling interests 0 0
Proceeds from the issuance of long-term debt   1,536,000
Principal payments on long-term debt   (1,257,965)
Payments for financing costs   (10,405)
Net Cash Provided by (Used in) Financing Activities, Continuing Operations (278,817) (93,077)
Net Cash Provided by (Used in) Continuing Operations 18,091 (8,095)
Effect of exchange rate changes on cash and cash equivalents 6,716 7,798
Cash and cash equivalents at end of period 25,127 268
Guarantor Subsidiaries [Member]    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities 1,180,996 498,874
Cash flows from investing activities:    
Capital expenditures (51,695) (47,811)
Return of capital from investees 0  
Investment in and loans to investees 0 0
Payments for acquisition of a business, net of cash acquired (675)  
Increase (decrease) to investment in affiliates (1,798,987) (394,117)
Net cash (used in) provided by investing activities (1,851,357) (441,928)
Cash flows from financing activities:    
Deemed repurchases of restricted stock units 0 0
Purchase of treasury stock 0 0
Proceeds from stock option exercises 0  
Principal payments on capital lease obligations (2,223) (2,019)
Distributions to noncontrolling interests 0 0
Proceeds from the issuance of long-term debt   0
Principal payments on long-term debt   0
Payments for financing costs   0
Net Cash Provided by (Used in) Financing Activities, Continuing Operations (2,223) (2,019)
Net Cash Provided by (Used in) Continuing Operations (672,584) 54,927
Effect of exchange rate changes on cash and cash equivalents 641,460 26,885
Cash and cash equivalents at end of period 360,124 402,762
Non-Guarantor Subsidiaries [Member]    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities (477,659) 11,714
Cash flows from investing activities:    
Capital expenditures (9,079) (13,983)
Return of capital from investees 523  
Investment in and loans to investees (90,080) (43,000)
Payments for acquisition of a business, net of cash acquired (34,879)  
Increase (decrease) to investment in affiliates 1,040,871 254,014
Net cash (used in) provided by investing activities 907,356 197,031
Cash flows from financing activities:    
Deemed repurchases of restricted stock units 0 0
Purchase of treasury stock 0 0
Proceeds from stock option exercises 0  
Principal payments on capital lease obligations (1,655) (1,409)
Distributions to noncontrolling interests (9,333) (16,110)
Proceeds from the issuance of long-term debt   0
Principal payments on long-term debt   0
Payments for financing costs   0
Net Cash Provided by (Used in) Financing Activities, Continuing Operations (10,988) (17,519)
Net Cash Provided by (Used in) Continuing Operations 418,709 191,226
Effect of exchange rate changes on cash and cash equivalents (406,458) (201,841)
Cash and cash equivalents at end of period $ 179,466 $ 149,259